Julio Núñez
Universitat de València(ES)Universidad de Los Andes(CO)University of Concepción(CL)Instituto de Salud Carlos III(ES)Hospital General de México(MX)Hospital Clínico Universitario de Valencia(ES)Centro de Investigación en Red en Enfermedades Cardiovasculares(ES)Hospital del Salvador(CL)Centre for Biomedical Network Research on Rare Diseases(ES)Armed Forces Hospital(SA)Centro de Investigación Biomédica en Red(ES)Equilibrium Research(GB)Clínica Dávila(CL)INCLIVA Health Research Institute(ES)Centro de Investigación Biomédica en Red de Cáncer(ES)International Renal Research Institute of Vicenza(IT)Hospital Universitario Ramón y Cajal(ES)Universidad de Sevilla(ES)
Publications by Year
Research Areas
Heart Failure Treatment and Management, Cardiovascular Function and Risk Factors, Cardiac Imaging and Diagnostics, Acute Myocardial Infarction Research, Diabetes Treatment and Management
Most-Cited Works
- → Semaglutide in Patients with Heart Failure with Preserved Ejection Fraction and Obesity(2023)1,275 cited
- → The Effect of Age on Mortality in Patients With COVID-19: A Meta-Analysis With 611,583 Subjects(2020)739 cited
- → Semaglutide in Patients with Obesity-Related Heart Failure and Type 2 Diabetes(2024)547 cited
- → Usefulness of the Neutrophil to Lymphocyte Ratio in Predicting Long-Term Mortality in ST Segment Elevation Myocardial Infarction(2008)505 cited
- → Genetic Etiology for Alcohol-Induced Cardiac Toxicity(2018)294 cited
- → Semaglutide versus placebo in people with obesity-related heart failure with preserved ejection fraction: a pooled analysis of the STEP-HFpEF and STEP-HFpEF DM randomised trials(2024)290 cited